chr11-1225711-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002458.3(MUC5B):āc.101A>Gā(p.Glu34Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,603,608 control chromosomes in the GnomAD database, including 47,266 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_002458.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUC5B | NM_002458.3 | c.101A>G | p.Glu34Gly | missense_variant | 2/49 | ENST00000529681.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUC5B | ENST00000529681.5 | c.101A>G | p.Glu34Gly | missense_variant | 2/49 | 5 | NM_002458.3 | P1 | |
MUC5B | ENST00000525715.5 | n.159A>G | non_coding_transcript_exon_variant | 2/26 | 1 |
Frequencies
GnomAD3 genomes AF: 0.269 AC: 40760AN: 151488Hom.: 5757 Cov.: 32
GnomAD3 exomes AF: 0.263 AC: 61220AN: 233150Hom.: 8560 AF XY: 0.262 AC XY: 33190AN XY: 126784
GnomAD4 exome AF: 0.231 AC: 335568AN: 1452004Hom.: 41497 Cov.: 33 AF XY: 0.232 AC XY: 167441AN XY: 721394
GnomAD4 genome AF: 0.269 AC: 40809AN: 151604Hom.: 5769 Cov.: 32 AF XY: 0.277 AC XY: 20500AN XY: 74060
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Glu34Gly in exon 2 of MUC5B: This variant is not expected to have clinical signi ficance because it has been identified in 29.6% (1174/3972) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs2672785). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at